Results 61 to 70 of about 26,268,555 (308)

First-Line Treatment for Advanced Pancreatic Cancer

JOP : Journal of the pancreas, 2013
Metastatic pancreatic cancer is a rapidly fatal disease with few therapeutic options. The authors summarize four abstracts (#148, #233, #158, #291) presented at the 2013 ASCO Gastrointestinal Cancers Symposium which were focused on novel agents for metastatic pancreatic cancer.
Nishi, Kothari, Muhammad Wasif, Saif, Richard, Kim   +2 more
openaire   +2 more sources

Death within one month by first line antifungal treatment choice.

, 2022
Death within one month by first line antifungal treatment choice.
Ugo Françoise (14059845), Philippe Abboud (669399), Mathieu Nacher (340458), Romain Blaizot (9243632), Loïc Epelboin (458049), Magalie Demar (301540), Pierre Couppié (342022), Paul Le Turnier (7829654), Félix Djossou (181807), Antoine Adenis (292334), Aude Lucarelli (5439455)   +10 more
core   +1 more source

Feeding, Fear, and Acceptance: Caregivers’ Experiences of Nutritional Support During Childhood Cancer Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose To explore caregivers' experiences and perceptions of the nutritional challenges faced by children and adolescents undergoing cancer treatment, including oral intake and the use of nutritional support. Methods This was a qualitative study based on focus groups with parents and caregivers at a Brazilian pediatric oncology hospital ...
Danyelle Apparecida Balsamão Marques, Mariana dos Santos Murra, Welinton Hirai, Ana Laura Balduino do Nascimento, Karla Emilia de Sá Rodrigues, Wilson Elias de Oliveira Junior   +5 more
wiley   +1 more source

Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network

Frontiers in Hematology
BackgroundWaldenström macroglobulinemia (WM) is a rare and indolent B-cell lymphoproliferative disorder with greater incidence in elderly patients where a precise algorithm of initial therapy is still not clear.
Vittorio Del Fabro, Uros Markovic, Sara Frazzetto, Sara Frazzetto, Roberta Sciortino, Claudia Bellofiore, Mary Ann Di Giorgio, Valerio Leotta, Anna Bulla, Angelo Curto Pelle, Federica Elia, Donato Mannina, Ugo Consoli, Giuseppe Mineo, Cesarina Giallongo, Cesarina Giallongo, Alessandra Romano, Alessandra Romano, Francesco Di Raimondo, Francesco Di Raimondo, Concetta Conticello   +20 more
doaj   +1 more source

Efficacy of Gemcitabine and Vinorelbine in First-line Treatment 
with Advanced Non-small Cell Lung Cancer: A Multicentre Retrospective Study

Chinese Journal of Lung Cancer, 2012
Background and objective Chemotherapy has become the mainstay of first-line therapy. Non-platinum containing drugs are characterized by favorable toxicity profiles and is better tolerated than platinum-based regimens.
Yongfeng YU, Li ZHANG, Zhisheng REN, Jiujun ZHAO, Zhongrui LI, Shun LU   +5 more
doaj   +1 more source

First-line treatment of chronic myeloid leukaemia [PDF]

Therapeutic Advances in Hematology, 2010
Since the introduction of imatinib just over a decade ago, there has been a dramatic change in the treatment and prognosis of early chronic phase chronic myeloid leukaemia (CML). This review article focuses on recent advances, culminating in the approval of nilotinib by the US Food and Drug Administration for the treatment of adult patients with newly ...
openaire   +2 more sources

Possible hampered effectiveness of second-line treatment with rituximab-containing chemotherapy without signs of rituximab resistance: a population-based study among patients with chronic lymphocytic leukemia

, 2020
Rituximab-containing chemotherapy remains a viable frontline treatment option for patients with chronic lymphocytic leukemia (CLL) in the era of novel agents.
Kater, Arnon P., van der Straten, Lina, Levin, Mark-David, van den Broek, Esther C., Dinmohamed, Avinash G., Doorduijn, Jeanette K., Posthuma, Eduardus F. M.   +6 more
core   +1 more source

Uncovering Inequities: The Role of Social Determinants of Health in Hospitalized Adolescents and Young Adults With Heavy Menstrual Bleeding

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Heavy menstrual bleeding (HMB) is a common condition among adolescents and young adults (AYAs) and is the leading cause of iron deficiency anemia (IDA) in this population. Growing evidence suggests that social determinants of health (SDOH) influence menstrual bleeding patterns, access to care, and treatment. However, no studies have
Maria Carter‐Febres, Cristina Tarango, Ashley Childress, Chunyan Liu, Evan Thomas, Jennifer Pomales, Eric S. Mullins   +6 more
wiley   +1 more source

Frequency of first- and second-line treatment.

, 2019
Frequency of first- and second-line treatment.
Thirupathi Pattipaka (6175754), Yulin Li (36434), Adrian Cassidy (6175760), Apar Kishor Ganti (6175763), Anita Appius (6175751), Andrea Feyereislova (6175757)   +5 more
core   +1 more source

The Impact of Tenapanor on Body Composition and Blood Pressure in Peritoneal Dialysis Patients: A Pilot Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Instruction Tenapanor potentially affects fluid volume and blood pressure. This study explored its effects on these parameters in patients undergoing peritoneal dialysis (PD). Methods We conducted a single‐arm, prospective observational study that enrolled 10 patients on PD with hyperphosphatemia who were newly initiated on tenapanor.
Shun Yoshida, Kengo Asahina, Keiichi Osano, Natsumi Saegusa, Kohei Yamamura, Kie Ohkoshi, Miho Shikata, Toshihisa Ishii, Makiko Konishi, Kazuya Takahashi, Kohei Uchimura, Ayumu Nakashima   +11 more
wiley   +1 more source